In the BioHarmony Drug Report Database

"Preview" Icon

Aztreonam

Azactam, Cayston (aztreonam) is a small molecule pharmaceutical. Aztreonam was first approved as Azactam on 1986-12-31. It is used to treat bacterial infections, cellulitis, endometritis, intraabdominal infections, and pseudomonas infections amongst others in the USA. It has been approved in Europe to treat cystic fibrosis and respiratory tract infections. Aztreonam’s patent is valid until 2021-12-20 (FDA).

 

Trade Name

 

Cayston
 

Common Name

 

aztreonam
 

ChEMBL ID

 

CHEMBL158
 

Indication

 

bacterial infections, cellulitis, cystic fibrosis, endometritis, intraabdominal infections, pseudomonas infections, respiratory tract infections, urinary tract infections
 

Drug Class

 

Image (chem structure or protein)

Aztreonam structure rendering